Life Sciences

In Vivo Imaging

How Bruker’s preclinical imaging solutions help to discover new drugs and significantly shorten time-to-market by delivering earlier and more highly predictive data.

Preclinical Imaging Life Sciences

Preclinical imaging plays a crucial role in understanding how the body works in both healthy and disease states and describing responses to physiological or environmental change. It provides important insights into disease mechanisms at organ, tissue, cell, and molecular levels.

Such knowledge informs the development of novel therapeutic strategies, which in turn improve patient outcomes and save lives. Preclinical imaging is also central to evaluating the effectiveness and safety of new treatments and describing drug distribution patterns before clinical use.

Cost-efficient and high-throughput longitudinal study of animal models can be achieved using anatomical evaluation techniques such as magnetic resonance imaging (MRI) and computed tomography (CT) alongside positron emission tomography (PET) and single-photon emission computed tomography (SPECT) for molecular visualizations.

Bruker has developed a wide portfolio of molecular imaging technologies to meet varying preclinical imaging requirements. It includes MRI and CT scanners specifically designed for in vivo rodent imaging, such as the 9.4 Tesla (T) small animal MRI scanner and the MicroCT scanner. Multimodal imaging is facilitated by the combination of technologies in a single, easy-to-use instrument, such as the Albira system that includes PET, SPECT and CT technologies and the PET/MR 3T that combines PET and MRI.

Related Applications

Neues aus der Onkologie

Vorantreiben der Erkenntnisse in der Krebsbehandlung mit präklinischer Forschung

Tumor Treatments

Study of the pathways used by tumors to grow and spread can identify promising novel targets to inform the development of new drugs. Tumor imaging is a powerful tool in the search for innovative therapeutic strategies that provide greater anti-cancer efficacy whilst having less detrimental effects to healthy tissues.

Zoology and Botany

The importance of non-destructive imaging in zoology and botany

Molecular Tracers and Contrast Agents

Imaging agents in preclinical research provide valuable information towards our understanding of disease models, and the findings are directly translatable to the clinic.


Bruker's preclinical imaging solutions - key players in achieving a functional assessment of the heart


Bruker have developed a range of imaging systems to facilitate preclinical imaging in endocrinological research. The EVOQ Elite liquid chromatography mass spectrometer provides sustained high sensitivity detection of endocrines with high-throughput, whilst the the Bruker AVANCE range provides cutting-edge NMR performance. Additionally, the Albira preclinical micro-PET system enables full-body mice PET scans, suitable for endocrinology studies.

Mineralized Tissues

Mineralized tissues such as bone and teeth lend themselves to microCT imaging because of natural X-ray contrast

Tumor Treatments New

Find more information on tumor treatments

Related Videos